mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |